Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phrase "Messenger RNA complementary to SA1 siRNA antisense strand" describes the specific mRNA sequence targeted by the antisense strand of the SA1 siRNA molecule. In RNA interference (RNAi), siRNA molecules are designed so their antisense strand pairs exactly with the target mRNA; on binding, this recruits the RNA-induced silencing complex (RISC), ultimately leading to mRNA cleavage and gene silencing. Such design is widely used in experimental and therapeutic settings to knock down expression of specific genes. However, mRNA sequences themselves are not canonical molecular targets—these designations should refer to the actual gene or protein encoded by the mRNA, not to the descriptive relationship between the mRNA and the siRNA[1][3][4]. If you need structured target data, it is advisable to replace "Messenger RNA complementary to SA1 siRNA antisense strand" with the actual gene or protein name that is being silenced or knocked down in the experiment.
Cleavage and degradation of complementary mRNA by the RNA-induced silencing complex (RISC) when loaded with the antisense strand of siRNA
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Messenger RNA complementary to SA1 siRNA antisense strand.